首页> 外国专利> Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage

Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage

机译:基质细胞衍生因子-1的蛋白酶抗性突变体在组织损伤修复中的作用

摘要

The present invention is directed stromal cell derived factor-1 peptides that have been mutated to make them resistant to digestion by the proteases dipeptidyl peptidase IV (DPPIV) and matrix metalloproteinase-2 (MMP-2) but which maintain the ability of native SDF-1 to attract T cells. The mutants may be attached to membranes formed by self-assembling peptides and then implanted at sites of tissue damage to help promote repair.
机译:本发明涉及定向基质细胞衍生的因子-1肽,其已被突变以使其对蛋白酶二肽基肽酶IV(DPPIV)和基质金属蛋白酶-2(MMP-2)的消化具有抗性,但仍保持天然SDF-的能力。 1吸引T细胞。突变体可以附着在由自组装肽形成的膜上,然后植入组织损伤部位以帮助促进修复。

著录项

  • 公开/公告号US9631005B2

    专利类型

  • 公开/公告日2017-04-25

    原文格式PDF

  • 申请/专利权人 THE BRIGHAM AND WOMENS HOSPITAL INC.;

    申请/专利号US201314039580

  • 发明设计人 RICHARD T. LEE;VINCENT SEGERS;

    申请日2013-09-27

  • 分类号A61K38/17;A61K38/10;C07K14/52;A61K38;

  • 国家 US

  • 入库时间 2022-08-21 13:44:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号